Microfluidic-formulated leukosome compositions and fabrication methods therefor
AssigneeThe Methodist Hospital
InventorsEnnio Tasciotti, Roberto Molinaro
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Methodist Hospital
InventorsEnnio Tasciotti, Roberto Molinaro
Estimating the term…
Disclosed are methods for designing and manufacturing biomimetic proteolipid nanovesicles using a microfluidic approach, and in particular, a NanoAssemblr®-based platform, which allows for the high-throughput, reproducible, and scalable production of nanoparticles, without affecting their pharmaceutical and biological properties. These nanovesicles, which are composed of synthetic phospholipids and cholesterol, enriched of leukocyte membranes, and surrounding an aqueous core, possess remarkable properties for targeting compounds of interest to particular mammalian cell and tissue types.
A method of preparing a population of biomimetic proteolipid nanovesicles composed of synthetic phospholipids and cholesterol, enriched of leukocyte membrane fragments, and surrounding an aqueous core, the method comprising:
The method of claim 5, wherein the efficiency of protein incorporation into the leukocyte membrane fragments is at least 40% to 60% higher than that of biosimilar nanovesicles prepared by conventional thin-layer evaporation.
Dependencies are inferred from the claim text.